FierceHealthcare FierceHealthIT FierceMobileHealthcare FierceHealthPayer
FierceHealthFinance FierceEMR FiercePracticeManagemtn Hospital Impact

SPOTLIGHT: Late-stage cancer patients are over-tested

Doing screening tests on patients whose life expectancy is extremely limited because of cancer is not cost-effective, according to a new study published in the Journal of the American Medical Association. The study examined the issue of overtesting in late-stage cancer and raises new questions about overdiagnosis and overtreatment in the healthcare system. Too many tests can raise anxiety in patients and lead to unneeded follow-up tests and treatments that can have serious complications, the study found. Article

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceHealthPayer Email Newsletter:
Be the first to comment


Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.